Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
© The Author(s). 2017
Received: 23 November 2016
Accepted: 3 April 2017
Published: 11 April 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|23 Nov 2016||Submitted||Original manuscript|
|29 Dec 2016||Reviewed||Reviewer Report - Guy Cammu|
|5 Jan 2017||Reviewed||Reviewer Report - Jan Schreiber|
|4 Feb 2017||Reviewed||Reviewer Report - Stefan Schaller|
|8 Mar 2017||Author responded||Author comments - Marie Aouad|
|Resubmission - Version 2|
|8 Mar 2017||Submitted||Manuscript version 2|
|29 Mar 2017||Author responded||Author comments - Marie Aouad|
|Resubmission - Version 3|
|29 Mar 2017||Submitted||Manuscript version 3|
|3 Apr 2017||Editorially accepted|
|11 Apr 2017||Article published||10.1186/s12871-017-0348-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.